logo

Fischer Medical Ventures Delivers Robust Q2FY26 Earnings with ₹13.9 Crore Net Profit.

By Shishta Dutta | Published at: Oct 29, 2025 12:32 PM IST

Fischer Medical Ventures Delivers Robust Q2FY26 Earnings with ₹13.9 Crore Net Profit.
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Chennai, October 29, 2025: In its latest announcement, Fischer Medical Ventures Limited reported a remarkable year-on-year improvement for the quarter ended September 30, 2025. The company’s consolidated profit after tax surged to ₹1,389.58 lakh, a substantial rise from ₹29.33 lakh recorded in the corresponding quarter of the previous fiscal year (Q2 FY25). Also, consolidated revenue from operations increased to ₹8,630.53 lakh, compared to less than half of that a year ago at ₹3,965.53 lakh, indicating widespread traction across the business.

Fischer Medical Ventures Limited deals in medical diagnostics and healthcare equipment. The company is listed on both the NSE and the BSE and has reported consolidated and standalone results for its operations.

Q2FY26 vs Q2FY25 Performance

For the quarter ending in September 2025, the company delivered strong operational performance. The revenue from operations grew 117.6% year-over-year to ₹8,630.53 lakh, total income rose 122.6%, and profit after tax grew 4,637.6% year-over-year to ₹1,389.58 lakh. Earnings Per Share increased sharply to ₹2.15, reflecting strong operational performance and higher profitability compared to Q2FY25.

Half-Year Snapshot

For the first half of the financial year 2025-26, total income was ₹11,969.78 lakh, compared to ₹5,074.12 lakh for the same period last year. Profit after tax was ₹1,890.40 lakh as compared to ₹17.62 lakh in the previous year’s H1. Paid-up equity share capital as of September 30th, 2025, was ₹6,485.15 lakh with other equity at ₹24,166.26 lakh.

Expense And Other Line Items

For Q2FY26, employee benefits amounted to ₹374.75 lakh, depreciation and amortization were ₹51.37 lakh, finance costs were ₹91.87 lakh, and other expenses were ₹466.75 lakh. Other income was ₹248.14 lakh in the quarter.

Share Market Performance

As of 10:55 am, the share price of Fischer Medical Ventures Limited was trading at ₹115.50, up ₹6.60 or 6.05% from its previous close of ₹109.10. The share opened at ₹118.65 and has traded between ₹121.45 and ₹113.05 so far. The P/E ratio of the company stood at 1,109.80, and the market cap was at 7,013.70 Cr.

REF: https://nsearchives.nseindia.com/corporate/FISCHER_28102025235440_FinalUploa.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy